Literature DB >> 16865358

Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects.

N Grarup1, S A Urhammer, J Ek, A Albrechtsen, C Glümer, K Borch-Johnsen, T Jørgensen, T Hansen, O Pedersen.   

Abstract

AIMS/HYPOTHESIS: Plasma cell membrane glycoprotein 1 (PC-1) inhibits insulin signalling by direct interaction with the insulin receptor alpha subunit. This inhibition is enhanced by the minor Q allele of the K121Q polymorphism (rs1044498) in the gene (ENPP1) encoding PC-1. This polymorphism has been studied in relation to insulin resistance, type 2 diabetes and obesity in several populations with conflicting results. We assessed the impact of the ENPP1 K121Q polymorphism on type 2 diabetes, obesity and quantitative metabolic traits in 7,333 Danes. SUBJECTS AND METHODS: The K121Q polymorphism was genotyped in the population-based Inter99 study cohort (5,961 subjects) and in a group of 1,386 patients with type 2 diabetes. All subjects were Danish whites.
RESULTS: No significant associations with type 2 diabetes or related quantitative metabolic traits, including measures of insulin resistance, were detected. However, a meta-analysis of the present and published studies revealed an association with type 2 diabetes (odds ratio per Q allele, 1.17 [95% CI 1.10-1.25], p=1x10(-6)). In case-control studies comparing subjects of different BMI strata, we observed a putative association of the codon 121 QQ genotype with being overweight (BMI>25 kg/m(2); odds ratio 1.63 [95% CI 1.09-2.46], p=0.015), an association not observed when comparing other levels of BMI or when analysing BMI as a quantitative trait. CONCLUSIONS/
INTERPRETATION: In a meta-analysis, the ENPP1 codon 121 Q allele associates with type 2 diabetes. However, a similar association was not found in the present study of Danish white subjects. The effect of this variant on obesity in Danish subjects is contentious and further study is needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865358     DOI: 10.1007/s00125-006-0353-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  41 in total

1.  Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study.

Authors:  Larry D Atwood; Nancy L Heard-Costa; L Adrienne Cupples; Cashell E Jaquish; Peter W F Wilson; Ralph B D'Agostino
Journal:  Am J Hum Genet       Date:  2002-09-27       Impact factor: 11.025

2.  Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia.

Authors:  Betty A Maddux; Yow-Ning Chang; Domenico Accili; Owen P McGuinness; Jack F Youngren; Ira D Goldfine
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11-08       Impact factor: 4.310

3.  The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians.

Authors:  S K Rasmussen; S A Urhammer; A Pizzuti; S M Echwald; C T Ekstrøm; L Hansen; T Hansen; K Borch-Johnsen; L Frittitta; V Trischitta; O Pedersen
Journal:  Diabetes       Date:  2000-09       Impact factor: 9.461

Review 4.  Molecular insights into insulin action and secretion.

Authors:  C J Rhodes; M F White
Journal:  Eur J Clin Invest       Date:  2002-06       Impact factor: 4.686

5.  Association of K121Q polymorphism in ENPP1 (PC-1) with BMI in Caucasian and African-American adults.

Authors:  N Matsuoka; A Patki; H K Tiwari; D B Allison; S B Johnson; P K Gregersen; R L Leibel; W K Chung
Journal:  Int J Obes (Lond)       Date:  2006-02       Impact factor: 5.095

6.  K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population.

Authors:  José Luis González-Sánchez; María Teresa Martínez-Larrad; Cristina Fernández-Pérez; Agata Kubaszek; Markku Laakso; Manuel Serrano-Ríos
Journal:  Obes Res       Date:  2003-05

7.  The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth.

Authors:  Agata Kubaszek; Anu Markkanen; Johan G Eriksson; Tom Forsen; Clive Osmond; David J P Barker; Markku Laakso
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

8.  High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  K H Buetow; M Edmonson; R MacDonald; R Clifford; P Yip; J Kelley; D P Little; R Strausberg; H Koester; C R Cantor; A Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

9.  A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes.

Authors:  Florence Demenais; Timo Kanninen; Cecilia M Lindgren; Steven Wiltshire; Stéphane Gaget; Candice Dandrieux; Peter Almgren; Marketa Sjögren; Andrew Hattersley; Christian Dina; Tiinamaija Tuomi; Mark I McCarthy; Philippe Froguel; Leif C Groop
Journal:  Hum Mol Genet       Date:  2003-08-01       Impact factor: 6.150

10.  The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes.

Authors:  S Ghosh; R M Watanabe; T T Valle; E R Hauser; V L Magnuson; C D Langefeld; D S Ally; K L Mohlke; K Silander; K Kohtamäki; P Chines; J Balow; G Birznieks; J Chang; W Eldridge; M R Erdos; Z E Karanjawala; J I Knapp; K Kudelko; C Martin; A Morales-Mena; A Musick; T Musick; C Pfahl; R Porter; J B Rayman
Journal:  Am J Hum Genet       Date:  2000-10-13       Impact factor: 11.043

View more
  36 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Recent progress in the genetics of common obesity.

Authors:  Ruth J F Loos
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

3.  The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention.

Authors:  K Müssig; M Heni; C Thamer; K Kantartzis; F Machicao; N Stefan; A Fritsche; H-U Häring; H Staiger
Journal:  Diabetologia       Date:  2009-11-29       Impact factor: 10.122

4.  Association of genetic variation in ENPP1 with obesity-related phenotypes.

Authors:  Christopher P Jenkinson; Dawn K Coletta; Marion Flechtner-Mors; Shirley L Hu; Marcel J Fourcaudot; Lenore M Rodriguez; Jennifer Schneider; Rector Arya; Michael P Stern; John Blangero; Ravindranath Duggirala; Ralph A DeFronzo
Journal:  Obesity (Silver Spring)       Date:  2008-05-08       Impact factor: 5.002

Review 5.  Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.

Authors:  Tyler J Severson; Siddesh Besur; Herbert L Bonkovsky
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

6.  Maternal-fetal metabolic gene-gene interactions and risk of neural tube defects.

Authors:  Philip J Lupo; Laura E Mitchell; Mark A Canfield; Gary M Shaw; Andrew F Olshan; Richard H Finnell; Huiping Zhu
Journal:  Mol Genet Metab       Date:  2013-11-18       Impact factor: 4.797

7.  Super-Obese Patient-Derived iPSC Hypothalamic Neurons Exhibit Obesogenic Signatures and Hormone Responses.

Authors:  Uthra Rajamani; Andrew R Gross; Brooke E Hjelm; Adolfo Sequeira; Marquis P Vawter; Jie Tang; Vineela Gangalapudi; Yizhou Wang; Allen M Andres; Roberta A Gottlieb; Dhruv Sareen
Journal:  Cell Stem Cell       Date:  2018-04-19       Impact factor: 24.633

Review 8.  Insulin signaling regulating genes: effect on T2DM and cardiovascular risk.

Authors:  Sabrina Prudente; Eleonora Morini; Vincenzo Trischitta
Journal:  Nat Rev Endocrinol       Date:  2009-12       Impact factor: 43.330

9.  Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study.

Authors:  Intissar Ezzidi; Nabil Mtiraoui; Stéphane Cauchi; Emmanuel Vaillant; Aurélie Dechaume; Molka Chaieb; Maha Kacem; Wassim Y Almawi; Philippe Froguel; Touhami Mahjoub; Martine Vaxillaire
Journal:  BMC Med Genet       Date:  2009-04-15       Impact factor: 2.103

10.  The 6th Annual World Congress on the insulin resistance syndrome.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2009-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.